Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers. [electronic resource]
- Vaccine 07 2017
- 3823-3833 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2017.05.090 doi
Cost-Benefit Analysis Global Health Humans Medication Reconciliation--economics Poliomyelitis--prevention & control Travel-Related Illness